Is Hemab Therapeutics Holdings, Inc. Common Stock overvalued?

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) — key valuation metrics and fundamentals.

No verdict

Price

$40.86

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$1.91B

Dividend yield

0.0%

Return on equity

-32.5%

Sector

Healthcare

Fair value compares COAG's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks